PACB · Pacific Biosciences Of California, Inc.
Market Cap
$435.16M
Shares
310.83M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-08-05 | 2026-07-30 | |
| 8-K | 2026-07-09 | 2026-07-08 | |
| 8-K | 2026-06-04 | 2026-06-03 | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-23 | 2026-06-03 | |
| 8-K | 2026-03-06 | 2026-03-02 | |
| 8-K | 2026-03-05 | 2026-03-03 | |
| 10-K | 2026-02-25 | 2025-12-31 | |
| 8-K | 2026-02-12 | — | |
| 8-K | 2026-02-03 | 2026-01-28 | |
| 8-K | 2026-02-02 | 2026-01-30 | |
| 8-K | 2026-01-12 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-06-06 | 2025-06-04 | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-23 | 2025-06-04 | |
| 8-K | 2025-04-09 | — | |
| 8-K | 2025-03-27 | 2025-03-24 | |
| 10-K | 2025-03-17 | 2024-12-31 | |
| 8-K | 2025-03-13 | 2025-03-07 | |
| 8-K | 2025-02-13 | — | |
| 8-K/A | 2025-02-07 | 2025-01-24 | |
| 8-K | 2025-01-30 | 2025-01-24 | |
| 8-K | 2025-01-14 | — | |
| 8-K | 2024-12-13 | 2024-12-11 | |
| 8-K/A | 2024-12-13 | 2024-11-11 | |
| 8-K | 2024-12-06 | 2024-12-05 | |
| 8-K | 2024-11-22 | 2024-11-21 | |
| 8-K | 2024-11-12 | 2024-11-11 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-11-07 | 2024-11-05 | |
| 10-Q | 2024-08-09 | 2024-06-30 | |
| 8-K/A | 2024-08-07 | 2024-04-16 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-06-20 | 2024-06-18 | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-29 | 2024-06-18 | |
| 8-K | 2024-04-16 | — | |
| 10-K | 2024-02-28 | 2023-12-31 | |
| 8-K | 2024-02-15 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-12-11 | 2023-12-07 |
Showing 1–50 of 128 filings